David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1501
Ambev
ABEV
$45.3B
| $7.51M | 0.01% |
3,223,811
+2,752,007
| +583% | +$5.5M |
|
1502
Antero Midstream
AM
$10.8B
| $7.51M | 0.01% |
417,235
+192,909
| +86% | +$3.19M |
|
1503
Integer Holdings
ITGR
$4.26B
| $7.51M | 0.01% |
63,628
+54,112
| +569% | +$7.08M |
|
1504
Ferguson
FERG
$46B
| $7.48M | 0.01% |
46,708
-407,848
| -90% | -$70.7M |
|
1505
PUT
XPeng
XPEV
$11.4B
| $7.47M | 0.01% |
360,700
+184,700
| +105% | +$3.33M |
|
1506
SolarEdge
SEDG
$1.97B
| $7.46M | 0.01% |
461,136
-1,083,002
| -70% | -$16.8M |
|
1507
CALL
Iron Mountain
IRM
$36.2B
| $7.46M | 0.01% |
86,700
-65,900
| -43% | -$6.35M |
|
1508
CALL
Wayfair
W
$14.3B
| $7.46M | 0.01% |
232,800
-113,800
| -33% | -$4.73M |
|
1509
Metropolitan Bank Holding Corp
MCB
$1.13B
| $7.45M | 0.01% |
133,133
+22,514
| +20% | +$1.34M |
|
1510
Fulgent Genetics
FLGT
$546M
| $7.44M | 0.01% |
440,016
+309,332
| +237% | +$5.27M |
|
1511
PUT
Roblox
RBLX
$27.6B
| $7.43M | 0.01% |
127,500
-205,100
| -62% | -$12.9M |
|
1512
CALL
Madrigal Pharmaceuticals
MDGL
$12B
| $7.42M | 0.01% |
22,400
-47,200
| -68% | -$15.5M |
|
1513
Aaon
AAON
$6.59B
| $7.42M | 0.01% |
94,955
+86,603
| +1,037% | +$8.93M |
|
1514
Nucor
NUE
$57.1B
| $7.4M | 0.01% |
61,500
-296,532
| -83% | -$38.2M |
|
1515
CALL
NuScale Power
SMR
$3.92B
| $7.4M | 0.01% |
522,400
-290,900
| -36% | -$5.88M |
|
1516
CALL
Eaton
ETN
$161B
| $7.39M | 0.01% |
27,200
-82,500
| -75% | -$25.7M |
|
1517
KB Financial Group
KB
$42.3B
| $7.38M | 0.01% |
136,474
+117,525
| +620% | +$6.79M |
|
1518
Celldex Therapeutics
CLDX
$3.21B
| $7.37M | 0.01% |
406,161
-112,179
| -22% | -$2.51M |
|
1519
Rapid7
RPD
$805M
| $7.37M | 0.01% |
277,999
+13,995
| +5% | +$476K |
|
|
SGI
1520
Somnigroup International
SGI
$13.6B
| $7.37M | 0.01% |
123,072
-224,901
| -65% | -$13.6M |
|
1521
PUT
AngloGold Ashanti
AU
$60.5B
| $7.35M | 0.01% |
198,100
+75,000
| +61% | +$2.3M |
|
1522
Community Health Systems
CYH
$415M
| $7.34M | 0.01% |
2,720,295
-151,860
| -5% | -$473K |
|
1523
Alkami Technology
ALKT
$2.14B
| $7.34M | 0.01% |
279,535
+51,831
| +23% | +$1.63M |
|
|
ACH
1524
Accendra Health
ACH
$89.2M
| $7.33M | 0.01% |
812,233
+148,515
| +22% | +$1.57M |
|
1525
Element Solutions
ESI
$8.76B
| $7.33M | 0.01% |
324,230
-6,757
| -2% | -$173K |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.